The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 04, 2016

Filed:

Oct. 14, 2014
Applicant:

Mead Johnson Nutrition Company, Glenview, IL (US);

Inventors:

Dirk Hondmann, Winnetka, IL (US);

Eric A. F. van Tol, Arnhem, NL;

Gabriele Gross, Nijmegen, NL;

Marieke H. Schoemaker, Rhenen, NL;

Teartse Tim Lambers, Nijmegen, NL;

Assignee:

Mead Johnson Nutrition Company, Glenview, IL (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A23L 1/305 (2006.01); A61K 38/08 (2006.01); A61K 31/202 (2006.01); A61K 31/70 (2006.01); A61K 35/741 (2015.01); A61K 38/07 (2006.01); A61K 38/01 (2006.01); A23L 1/30 (2006.01); A23L 1/29 (2006.01); A61K 38/06 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 38/08 (2013.01); A23L 1/296 (2013.01); A23L 1/3014 (2013.01); A23L 1/3053 (2013.01); A61K 31/202 (2013.01); A61K 31/70 (2013.01); A61K 35/741 (2013.01); A61K 38/018 (2013.01); A61K 38/06 (2013.01); A61K 38/07 (2013.01); A61K 45/06 (2013.01); A23V 2002/00 (2013.01);
Abstract

The present disclosure relates to nutritional compositions comprising a protein equivalent source, wherein 20% to 80% of the protein equivalent source includes a peptide component comprising SEQ ID NO 4, SEQ ID NO 13, SEQ ID NO 17, SEQ ID NO 21, SEQ ID NO 24, SEQ ID NO 30, SEQ ID NO 31, SEQ ID NO 32, SEQ ID NO 51, SEQ ID NO 57, SEQ ID NO 60, and SEQ ID NO 63, and 20% to 80% of the protein equivalent source comprises an intact protein, a partially hydrolyzed protein, or combinations thereof. The disclosure further relates to methods of reducing the inflammatory response and/or production of proinflammatory cytokines, i.e. Interleukin-17, by providing said nutritional compositions to a target subject.


Find Patent Forward Citations

Loading…